Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-14
1997-02-18
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544165, 548204, 548248, 549 71, 549 77, 549366, 549373, 549378, 549467, 549494, 560 73, 560107, 560252, A61K 31335, C07D31906
Patent
active
056042566
ABSTRACT:
Compounds of formula (I): ##STR1## (in which: R is hydrogen, methyl or hydroxy; X is alkyl, alkenyl, cycloalkyl, aryl, aralkyl, or a heterocyclic group; A is a single bond, or an alkylene, alkenylene, alkynylene or alkadienylene group; Y is hydrogen, aryl, cycloalkyl or a heterocyclic group) have the ability to inhibit the biosynthesis of cholesterol, and can thus be used for the treatment and prophylaxis of diseases relating to high blood cholesterol levels.
REFERENCES:
patent: 4997848 (1991-03-01), Kurabayashi et al.
Heathcock et al, "Synthesis and Biological Evaluation of a Monocyclic, Fully Functional Analogue of Compactin", J. Med. Chem., 32, 197-202, (1989).
Iwabuchi Haruo
Koga Teiichiro
Kogen Hiroshi
Komai Toru
Kurabayashi Masaaki
Ramsuer Robert W.
Sankyo Company Limited
LandOfFree
Octahydronaphthalene oxime derivatives for cholesterol biosynthe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Octahydronaphthalene oxime derivatives for cholesterol biosynthe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octahydronaphthalene oxime derivatives for cholesterol biosynthe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1602848